Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...

In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — ...

Judi Health expanded its healthcare network to offer specialized virtual care for cancer, autoimmune and GI conditions while ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

A new class action lawsuit accuses Oura of overstating its smart ring's sleep tracking accuracy, arguing the device relies on ...

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory ...

A roundup of the seven most notable hospital mergers and acquisitions announced or completed this summer, including Prisma Health’s acquisition of Erlanger Health and Sanford Health’s purchase of Nort ...

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder ...